These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7798461)

  • 1. The role of psychosocial and biological variables in separating chronic and non-chronic major depression and early-late-onset dysthymia.
    Szádóczky E; Fazekas I; Rihmer Z; Arató M
    J Affect Disord; 1994 Sep; 32(1):1-11. PubMed ID: 7798461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unreliability of TRH test but not dexamethasone suppression test as a marker of depression in chronic vasculopathic patients.
    Marchesi C; Silvestrini C; Ponari O; Volpi R; Chiodera P; Coiro V
    Biol Psychiatry; 1996 Oct; 40(7):637-41. PubMed ID: 8886297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone suppression test and TRH-TSH test in subaffective dysthymia and character-spectrum disorder.
    Rihmer Z; Szádoczky E
    J Affect Disord; 1993 Aug; 28(4):287-91. PubMed ID: 8227765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine investigation in children and adolescents with dysthymic disorders: the DST, TRH and clonidine tests.
    Brambilla F; Musetti C; Tacchini C; Fontanillas J; Guareschi-Cazzullo A
    J Affect Disord; 1989; 17(3):279-84. PubMed ID: 2529297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation of dexamethasone suppression test and thyrotropin-releasing hormone test results in different subtypes of depression.
    D'Haenen H; Kaufman L; De Weert D; Cornet C; Raets I
    Acta Psychiatr Belg; 1984; 84(3):228-34. PubMed ID: 6435395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The thyrotropin-releasing hormone and dexamethasone suppression tests in the familial classification of depression.
    Fleming JE; Extein I; Sternbach HA; Pottash AL; Gold MS
    Psychiatry Res; 1983 May; 9(1):53-8. PubMed ID: 6412261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological and clinical features of recurrent brief depression: a comparison with major depressed and healthy subjects.
    Staner L; De La Fuente JM; Kerkhofs M; Linkowski P; Mendlewicz J
    J Affect Disord; 1992 Dec; 26(4):241-5. PubMed ID: 1479136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Weissenburger JE; Fulton CL; Fairchild CJ; Roffwarg HP
    Biol Psychiatry; 1997 May; 41(9):915-28. PubMed ID: 9110097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine abnormalities in affective disorders.
    Extein I; Pottash AL; Gold MS
    Encephale; 1982; 8(2):203-11. PubMed ID: 6809445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of the combined dexamethasone suppression and TRH/TSH tests in melancholia.
    Steiner M; Goldman SE; Gupta RN; Boiago IM; Pellettier JR
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):655-9. PubMed ID: 3937177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TRH stimulation test and the dexamethasone suppression test in depression.
    Dam H; Mellerup ET; Rafaelsen OJ
    Psychiatry Res; 1986 Apr; 17(4):309-16. PubMed ID: 3086912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRH tests with analyses of TSH, prolactin, and GH responses in subtypes of patients with major depressive disorders.
    Agren H; Wide L
    Acta Psychiatr Scand; 1986 May; 73(5):549-58. PubMed ID: 3092581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone suppression test, TRH test and Newcastle II depression rating in the diagnosis of depressive disorders.
    Larsen JK; Bjørum N; Kirkegaard C; Aggernaes H; Krog-Meyer I; Lund-Laursen AM; Mikkelsen PL
    Acta Psychiatr Scand; 1985 May; 71(5):499-505. PubMed ID: 3925727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of depressive history on biological parameters in major depression].
    Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P
    Encephale; 2002; 28(1):51-8. PubMed ID: 11963343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of DST and TRH test administration on depression assessments: a controlled study.
    Lafer B; Fava M; Hammerness P; Rosenbaum JF
    Biol Psychiatry; 1993 Nov; 34(9):650-3. PubMed ID: 8292694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone suppression test and TRH test in endogenous depression.
    Aggernaes H; Kirkegaard C; Krog-Meyer I; Kijne B; Larsen JK; Laursen AL; Lykke-Olesen L; Mikkelsen PL; Rasmussen S; Bjørum N
    Acta Psychiatr Scand; 1983 Apr; 67(4):258-64. PubMed ID: 6407280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dexamethasone suppression and thyrotropin-releasing hormone tests in depressed borderline patients.
    Sternbach HA; Fleming J; Extein I; Pottash AL; Gold MS
    Psychoneuroendocrinology; 1983; 8(4):459-62. PubMed ID: 6425891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of the DST and the TRH test for major depression in alcoholics.
    Dackis CA; Bailey J; Pottash AL; Stuckey RF; Extein IL; Gold MS
    Am J Psychiatry; 1984 May; 141(5):680-3. PubMed ID: 6424482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationships of neuroendocrine tests in endogenous depression.
    Arató M; Rihmer Z; Bánki CM; Grof P
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):715-8. PubMed ID: 6420844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine challenge tests in depression: a study of growth hormone, TRH and cortisol release.
    Barry S; Dinan TG
    J Affect Disord; 1990 Apr; 18(4):229-34. PubMed ID: 2140374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.